[1]
Joaquín Borrás-Blasco, “Response to Ustekinumab in a Patient with Severe Psoriasis when Adalimumab Dose Escalation Fails ”, J. Pharm. Nutr. Sci., vol. 4, no. 2, pp. 131–134, May 2014.